Try it
Biochemistry · Nucleotide drugs: fluorouracil
Sample itemA patient with colorectal cancer receives fluorouracil. The active metabolite FdUMP forms a covalent complex with thymidylate synthase. Which intracellular change is expected?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Decreased dTMP with accumulation of dUMP
Thymidylate synthase converts dUMP to dTMP using N5,N10-methylene tetrahydrofolate as the methyl donor. FdUMP traps the enzyme in a ternary complex, so dTMP falls and dUMP accumulates, causing so-called thymineless death in dividing cells. Leucovorin stabilises the complex and enhances the effect.
Option by option
A. Decreased dUMP with accumulation of dTMP
This is the reverse of the effect, since dUMP is the substrate and builds up.
B. Decreased dTMP with accumulation of dUMP (correct)
Correct. Blocking thymidylate synthase lowers the product dTMP and raises its substrate dUMP.
C. Decreased dCDP with accumulation of CDP
dCDP and CDP changes would arise from ribonucleotide reductase inhibition, as with hydroxyurea.
D. Decreased IMP with accumulation of PRPP
IMP and PRPP changes would arise from blocking purine synthesis, as with 6-mercaptopurine.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…